4-methylthioamphetamine has been researched along with lysergic acid diethylamide in 2 studies
| Studies (4-methylthioamphetamine) | Trials (4-methylthioamphetamine) | Recent Studies (post-2010) (4-methylthioamphetamine) | Studies (lysergic acid diethylamide) | Trials (lysergic acid diethylamide) | Recent Studies (post-2010) (lysergic acid diethylamide) |
|---|---|---|---|---|---|
| 38 | 0 | 9 | 5,146 | 161 | 454 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurrasch, D; Marona-Lewicka, D; Nichols, DE; Parker, MA; Shulgin, AT | 1 |
| Nichols, D | 1 |
2 other study(ies) available for 4-methylthioamphetamine and lysergic acid diethylamide
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA).
Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents; Behavior, Animal; Brain; Dioxoles; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Serotonin Agents; Synaptosomes | 1998 |
Legal highs: the dark side of medicinal chemistry.
Topics: Amphetamines; Animals; Depression; Designer Drugs; Drug Design; Electronic Mail; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease; Research Personnel; Schizophrenia; Substance-Related Disorders | 2011 |